Travere Therapeutics: Establishing A Position After Last Week's Selloff

Group 1 - The biotech forum has seen significant discussions around profitable buy-write or covered call strategies on selected biotech stocks in recent months [1] - Travere Therapeutics, Inc. (NASDAQ: TVTX) is highlighted for its impressive sales growth in Q1, despite a recent pullback in stock price and a notable reduction in losses [2] - The investing group, The Biotech Forum, offers a model portfolio featuring 12-20 high upside biotech stocks, along with live chat for trade ideas and weekly market commentary [2]